Spring direct naar de hoofdnavigatie of de inhoud

EMA is good for the Netherlands’ innovation climate

The relocation of the European Medicines Agency (EMA) to Amsterdam will provide a boost to the region as a location for international and knowledge-intensive companies to establish themselves. The Agency determines which medicines are granted access to the European market. There are many medical sector companies that will be pleased to be based close to the EMA. It is therefore expected that some of those companies will follow the EMA to our country.

Also see these experts

Hajo Kraak

Hajo Kraak

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
Blijke Kroezen

Blijke Kroezen

  • European and Dutch Patent Attorney, European Patent Litigator
  • Associate
More experts